Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Quelling of Excitotoxicity in Acute Stroke With Ketamine


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03223220

Organisation Name: Lower Merion Neurology Research Foundation

Overal Status: Not yet recruiting

Start Date: January 1, 2023

Last Update: October 14, 2022

Lead Sponsor: Lower Merion Neurology Research Foundation

Brief Summary: The investigators plan to undertake a phase II study to investigate the efficacy and side effects of intravenous ketamine to reduce neuroexcitotoxicity, and thus provide neuroprotection in patients diagnosed with acute ischemic stroke.

Conditions:
  • Acute Ischemic Stroke


Total execution time in seconds: 0.21905612945557